In this analysis, only the ultra high AT-rich regions (the putative PCENs) of P. falciparum were used. Sequences were obtained from PlasmoDB Top-scoring sequences were shown in TABLE. a: Two consensus sequence motives were found in the one repetitive region of pfcen7.
SUPPLEMENTAL EXPERIMENTAL PROCEDURES Computational Analysis of PCEN Regions
Sequence analysis of the PCENs was carried out using Artemis 10 software.
The following DNA sequences were used: 1) Putatively annotated PCENs of P.
falciparum, downloaded from PlasmoDB (http://plasmodb.org/plasmo/), 2)
existing P. yoelii DNA sequences from chromosomes 5 and 13 containing the putative centromeres, including the 4.5 kb fragment containing pycen5 (GenBank accession no. DQ054838.1) and the 4.1 kb fragment containing pycen13 (GenBank accession no. DQ054839.1), retrieved from GenBank (www.ncbi.nlm.nih.gov/sites/entrez?db=nucleotide), and 3) the 3.8 kb DNA sequence containing pbcen5 (GenBank accession no. GU809989). These DNA sequences were analyzed using Artemis 10, their respective AT contents were analyzed using a scanning window (120 bp), and the output was visualized graphically. The ultra-high A/T-rich regions within each query sequence were identified using base composition graphics and termed the putative Plasmodium centromeres (PCENs). To identify repetitive regions within the PCENs, dot matrix analyses of PCENs were carried out using Dotlet with a window size of 15 bp. In these analyses, sequence identity was only recorded if the sequence identity within the 15 bp window was > 80%. The presence and locations of sequence elements in each repetitive region were identified using the program Tandem Repeats Finder. The sequences and arrangements of any repetitive regions within the various PCENs were characterized using the default settings.
Cloning of Putative Centromere of Plasmodium spp.
P. berghei ANKA, P. yoelii 17NL, and P. falciparum 3D7 strains were used for cloning of the Plasmodium putative centromere regions. DNA fragments including the putative centromeres of chromosome 5 of P. berghei (pbcen5) and chromosome 5 of P. yoelii (pycen5) were amplified using the same primers, P1:
5′-TCATGTGATGTTTACAACTGTGTC-3′ and P2:
5′-AAAAATGTAATTGCCAAAAAGG-3′, with genomic DNA as a template, resulting in fragments of 3.8 kb and 4.5 kb, respectively. The DNA fragment containing the putative centromere of chromosome 3 of P. falciparum (pfcen3) was amplified by a two-step PCR procedure. First, a fragment was amplified using the primer pair P3: 5′-TAATATACAAATATAAATCATGC-3′ and P4:
5′-ATAACATATAATAAATTAATTAGC-3′ from genomic DNA. Next, a DNA fragment of 2.5 kb including pfcen3 was amplified with the primers P5:
5′-ATATAAAGCTTAGTATTATTTATATG-3′ and P6:
5′-TAGGTACCAAATAATAAATACACATC-3′, using the first-step PCR fragment as template DNA. In addition, we amplified a 1.4-kb fragment including pbcen5
(1189 bp) with the primer set P7:
5′-TAGACAAACAAAATGATTATGATACAAATAC-3′ and P8:
5′-TTATAGGGTTATATTTTATAAGAAATAAGG-3′, using the 3.8-kb fragment as template DNA. Two truncated forms of pbcen5 termed pbcen5-core (973 bp) and pbcen5-rep (460 bp), were amplified by PCR using the primer pairs P9:
5′-GCTTATATATCAATTAATAATTATTATTATGC-3′ and P10:
5′-TAGACAAACAAAATGATTATGATACAAATAC-3′ for pbcen5-core, and P11:
5′-CGATAATAATAATTATTAATTGATATATAAGC-3′ and P12:
5′-TTATAGGGTTATATTTTATAAGAAATAAGG-3′ for pbcen5-rep. All amplified PCR fragments were cloned into the pCR2.1-TOPO vector (Invitrogen).
Cloning of Telomeric Sequences of P. berghei
We used an existing DNA fragment containing telomeric sequences of P. berghei (ANKA strain) that had previously been cloned into pUC19 . To introduce restriction sites at both ends of the telomeric fragment, PCR was performed with the primer pair P13: 5′-CACCGAAACGCGCGAGTTTAAACCC-3′ and P14:
5′-AAGCTTGCGGCCGCTGACCATGATTACGAAATCCC-3′, resulting in a 0.2-kb telomeric DNA fragment with newly introduced PmeI and HindIII restriction sites. The amplified fragment was cloned into the pCR2.1-TOPO vector twice and oriented in a 'face-to-face' arrangement with an approximately 500-bp intervening spacer region containing a PmeI restriction site, resulting in pTopo-TEL-TEL.
Transfection of PCEN Plasmids and PACs into Blood Stages of P. berghei
All PCEN plasmids used for transfection were purified using a Qiagen Plasmid
Midi kit (Qiagen). The L-PAC was generated by PmeI digestion, as described above. Five micrograms of each DNA construct were transfected into P. berghei (ANKA strain) blood-stage schizonts using standard Amaxa transfection technology, as described previously . Transfected parasites were injected into Swiss mice (~20 g) and selected by pyrimethamine treatment of the animals.
Each construct was used for at least two separate transfections to generate two independent transfectant parasite lines.
